The effect of alcohol consumption in the treatment of nontuberculous mycobacteria

M. Jacob (Porto, Portugal), R. Silva (Porto, Portugal), R. Gaio (Porto, Portugal), R. Duarte (Porto, Portugal), B. Ahlers (Bethany.Ahlers@uvm.edu / University of Vermont, V. Genetics Network,Burlington, V. , C. Hood (Catrina.Hood@uvm.edu / University of Vermont, V. Genetics Network,Burlington, V. , B. Deng (Bin.Deng@uvm.edu / University of Vermont, D. of Biology,Burlington, V. , Y. Lam (Ying-Wai.Lam@uvm.edu / University of Vermont, D. of Biology,Burlington, V. , E. Beatman (BeatmanE@NJHealth.org / National Jewish Health,Denver, C. , K. Schweitzer (SchweitzerK@NJHealth.org / National Jewish Health, D. of Pulmonary, C. Care and Sleep Medicine,Denver, C. , I. Petrache (PetracheI@NJHealth.org / National Jewish Health, D. of Pulmonary, C. Care and Sleep Medicine,Denver, C. , D. Weiss (daniel.weiss@uvm.edu / University of Vermont, C. of Medicine,Burlington, V. , D. Wagner (darcy.wagner@med.lu.se / Lund University,Lund)

Source: International Congress 2018 – Challenges in treating tuberculosis and nontuberculous mycobacteria
Session: Challenges in treating tuberculosis and nontuberculous mycobacteria
Session type: Poster Discussion
Number: 539
Disease area: Respiratory infections

Congress or journal article abstract

Abstract

Background: the incidence of nontuberculous mycobacteria (NTM) disease is increasing and its presentation and severity can vary. Treatment of NTM disease is long, requires multiple drugs and the overall outcome can be related to host factors.

Aim: to identify the effect of the alcohol consumption on the treatment outcome, crude and adjusted for other host variables.

Methods: a retrospective analysis of patients with NTM disease between 2003-2016 (data from the Portuguese National Epidemiological Surveillance Commission for TB). Logistic regression models assessed odds ratios (OR) with 95% confidence interval (CI) for an unsuccessful treatment outcome.

Results: 610 patients were included, 540 (89%) had lung NTM disease. The average age was 58±18.2 years and 369 were male patients. Five hundred and seventeen (84.8%) patients finished treatment successfully (good outcome) and 93 (15.2%) died while in treatment (bad outcome). The crude OR for alcohol consumption was 3.48 (95% CI1.91-6.21 p<0.001). In multivariate analysis, alcohol consumption was associated with bad outcome (OR 2.01, 95%CI 1.05-3.87 p<0.001). This effect was adjusted for history of chronic lung disease and other co-morbidities (OR 2.78, 95%CI 1.22-4.63 p=0.013), cancer (OR 4.47, 95%CI 1.86-10.72, p=0.001), at least one previous treatment (OR 1.86, 95% CI1.01-3.43 p=0.023) and HIV-infection (OR 2.09, 95%CI 1.2-3.97 p=0.001). Female gender was significantly identified as protective factor.

Conclusion: after adjustment for potential risk factors, alcohol consumption was estimated to double the odds for an unsuccessful outcome. This underlines the need of close monitoring among patients with alcohol dependencies to improve treatment outcomes.



Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Jacob (Porto, Portugal), R. Silva (Porto, Portugal), R. Gaio (Porto, Portugal), R. Duarte (Porto, Portugal), B. Ahlers (Bethany.Ahlers@uvm.edu / University of Vermont, V. Genetics Network,Burlington, V. , C. Hood (Catrina.Hood@uvm.edu / University of Vermont, V. Genetics Network,Burlington, V. , B. Deng (Bin.Deng@uvm.edu / University of Vermont, D. of Biology,Burlington, V. , Y. Lam (Ying-Wai.Lam@uvm.edu / University of Vermont, D. of Biology,Burlington, V. , E. Beatman (BeatmanE@NJHealth.org / National Jewish Health,Denver, C. , K. Schweitzer (SchweitzerK@NJHealth.org / National Jewish Health, D. of Pulmonary, C. Care and Sleep Medicine,Denver, C. , I. Petrache (PetracheI@NJHealth.org / National Jewish Health, D. of Pulmonary, C. Care and Sleep Medicine,Denver, C. , D. Weiss (daniel.weiss@uvm.edu / University of Vermont, C. of Medicine,Burlington, V. , D. Wagner (darcy.wagner@med.lu.se / Lund University,Lund). The effect of alcohol consumption in the treatment of nontuberculous mycobacteria. 539

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Consuming alcohol among tuberculosis patients and the influence to therapy
Source: Eur Respir J 2007; 30: Suppl. 51, 423s
Year: 2007

Evaluating the non-tuberculous mycobacteria effect in the tuberculosis infection diagnosis
Source: Eur Respir J 2010; 35: 338-342
Year: 2010



The effect of alcohol use on course of tuberculosis disease
Source: Annual Congress 2003 - Clinical aspects of tuberculosis
Year: 2003


Treatment of pulmonary NTM infection: can it be done?
Source: Annual Congress 2007 - Nontuberculous mycobacteria (NTM): a slow-growing challenge
Year: 2007


Non-tuberculous mycobacteria effect in the diagnosis of latent tuberculosis infection in children
Source: Annual Congress 2010 - Nontuberculous mycobacterial infections and tuberculosis
Year: 2010

The effect of tobacco smoking on drug sensitivity and microbiological characteristics of Mycobacterium tuberculosis (MTB): clinical and experimental study
Source: Eur Respir J 2003; 22: Suppl. 45, 158s
Year: 2003

Adverse effects of chemotherapy in patients with multidrug-resistant tuberculosis with alcohol abuse and without one
Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis
Year: 2018

Inhaled corticosteroids and the increased risk of non-tuberculous mycobacteria infection
Source: International Congress 2019 – Exploring the link between inhaled corticosteroids and respiratory infection
Year: 2019


Nontuberculous mycobacteriosis - from diagnosis to therapy
Source: Annual Congress 2005 - Management of tuberculosis pulmonary, extrapulmonary peculiarities
Year: 2005


The effect of cigarette smoking on pulmonary tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 489s
Year: 2005

The effect of the tobacco smoke condensate (TSC) on the structural changes in Mycobacterium tuberculosis (MTB)
Source: Annual Congress 2005 - Passive smoking and passive doctors
Year: 2005


Frequency of mycobacteriosis among the patients with positive cultures of nontuberculous mycobacteria (NTM) – 5 year study
Source: Eur Respir J 2004; 24: Suppl. 48, 190s
Year: 2004

The management of non-tuberculous mycobacteria
Source: International Congress 2016 – New therapies for chronic respiratory infections
Year: 2016


Nontuberculous mycobacteria in non-HIV patients: epidemiology, treatment and response
Source: Eur Respir J 2004; 23: 741-746
Year: 2004



How does tobacco-smoking contribute to the tuberculosis burden?
Source: Annual Congress 2007 - Tuberculosis control and HIV in Europe: good or bad news?
Year: 2007


Pathogenicity of NTM: new developments
Source: Annual Congress 2007 - Nontuberculous mycobacteria (NTM): a slow-growing challenge
Year: 2007


Targeting harmful use of alcohol for prevention and treatment of tuberculosis: a call for action
Source: Eur Respir J, 50 (1) 1700946; 10.1183/13993003.00946-2017
Year: 2017



A study of patients with pulmonary tuberculosis and confirmed coexistence of nontuberculous mycobacteria during treatment: Does the use of the additional acid-fast bacilli sputum test lead to shorter hospitalization?
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014


Identification of nontuberculous mycobacteria (NTM) isolated from patients from the TB hospital
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019

Nontuberculous mycobacteria in bronchiectasis: prevalence and patient characteristics
Source: Eur Respir J 2006; 28: 1204-1210
Year: 2006